Reply to: Commentary to Josef Tacke, et al. The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI Segment
- 10 May 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in CardioVascular and Interventional Radiology
- Vol. 43 (7), 1099
- https://doi.org/10.1007/s00270-020-02464-y
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial DiseaseJournal of the American College of Cardiology, 2019
- Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery RevascularizationVascular and Endovascular Surgery, 2017
- Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal ArteryCirculation, 2016
- Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal ArteriesJournal of Endovascular Therapy, 2015
- Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional StentingCirculation, 2007